Taking a daily aspirin won’t prevent heart deaths in those without established heart disease, but taking the combination cholesterol-lowering drug ezetimibe plus simvastatin (Vytorin) could prevent heart attacks and strokes in high-risk heart patients who recently had a heart attack or life-threatening chest pain, according to new research. Christopher Cannon, professor of medicine at Brigham and Women’s Hospital, led the study.
Trending News
Research Provides Clues to Spleen’s Role in Coronary Artery Disease
Genetic variants may drive visible changes in the spleen that contribute to heart disease
Patient Who Received Pig Kidney Becomes First To Progress to Human Kidney Transplant
Study shows xenotransplantation can serve as a bridge for patients with end-stage kidney disease
Pilots, Flight Attendants Have Greater Risk of Radiation-Related Cancer Death Than Other Professions
Findings support efforts to protect U.S. aircrews from cosmic radiation exposure